Neuralink co-founder Max Hodak's Science Corp, which offers a retinal implant for age-related macular degeneration, raised $400M at a $3.5B valuation (Ike Swetlitz/Bloomberg)
Science Corp, the company behind a retinal chip that restores some vision to people with an age-related form of blindness, is valued at $3.5 billion after a recent fundraising round.
We haven't written up this one. Techmeme has the full story — the link below goes straight to it.